Sensitisation of ovarian cancer cells to cisplatin by flavonoids from Scutellaria barbata

Natural Product Research

Volumn 28, Issue 10, 2014, Pages 683-689

  Li, Jie ^a   Wang, Yun ^a   Lei, Jia Chuan ^a   Hao, Yang ^a   Yang, Yuan ^a   Yang, Cheng Xiong ^b   Yu, Jian Qing ^a  

^a WUHAN UNIVERSITY   (China)

^b JINGCHU UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Antioxidant; Cisplatin; Flavonoids; Ovarian cancer; Scutellaria barbata

Indexed keywords

5,7,4' TRIHYDROXY 6 METHOXYFLAVANONE; 5,7,4' TRIHYDROXY 8 METHOXYFLAVANONE; APIGENIN; CHLORMETHINE; CISPLATIN; FLAVONOID; HYDROXYL GROUP; LUTEOLIN; QUERCETIN; QUERCETIN 4' O BETA DEXTRO GLUCOSIDE; REACTIVE OXYGEN METABOLITE; SCUTELLAREIN; SCUTELLARIN; UNCLASSIFIED DRUG; WOGONIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CELL CULTURE; CELL VIABILITY; DRUG EFFECT; DRUG SENSITIZATION; FEMALE; HUMAN; HUMAN CELL; OVARY CANCER; SCUTELLARIA BARBATA;

SCUTELLARIA BARBATA;

ANTIOXIDANT; CISPLATIN; FLAVONOIDS; OVARIAN CANCER; SCUTELLARIA BARBATA;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CISPLATIN; DRUG SYNERGISM; FEMALE; FLAVONOIDS; HUMANS; OVARIAN NEOPLASMS; PICRATES; SCUTELLARIA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84900396748     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2013.871547     Document Type: Article

References (15)

1. Arafa el-SA, Zhu Q, Barakat BM, Wani G, Zhao Q, El-Mahdy MA, Wani AA. 2009. Tangeretin sensitizes cisplatinresistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Res. 69:8910-8917
2. Goh D, Lee YH, Ong ES. 2005. Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agric Food Chem. 53:8197-8204
3. Jiangsu New Medical College. 1977. Dictionary of Chinese Materia Medical. Shanghai: Science and Technology Press of Shanghai
4. Khan N, Hadi N, Afaq F, Syed DN, Kweon MH, Mukhtar H. 2007. Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis. 28:163-173
5. Kosmider B, Osiecka R. 2004. Flavonoid compounds: A review of anticancer properties and interactions with cisdiamminedichloroplatinum(II). Drug Develop Res. 63:200-211
6. Li CJ, Chu CY, Huang LH, Wang MH, Sheu LF, Yeh JI, Hsu HY. 2012. Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo. Cancer Lett. 319:203-213
7. Liu LZ, Hu XW, Xia C, He J, Zhou Q, Shi X, Fang J, Jiang BH. 2006. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1a expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Rad Biol Med. 41:1521-1533
8. Luo H, Daddysman MK, Rankin GO, Jiang BH, Chen YC. 2010. Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. Cancer Cell Int. 10:16
9. Nam TW, Yoo CI, Kim HT, Kwon CH, Park JY, Kim YK. 2008. The flavonoid quercetin induces apoptosis and inhibits migration through a MAPK-dependent mechanism in osteoblasts. J Bone Min Metab. 26:551-560
10. Nijveldt RJ, Nood E, Hoorn DEC, Boelens PG, Norren K, Leeuwen PAM. 2001. Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr. 74:418-425
11. Pinato DJ, Graham J, Gabra H, Sharma R. 2013. Evolving concepts in the management of drug resistant ovarian cancer: Dose dense chemotherapy and the reversal of clinical platinum resistance. Cancer Treatment Rev. 39:153-160
12. Serpeloni JM, Barcelos GR, Friedmann Angeli JP, Mercadante AZ, Lourdes Pires Bianchi M, Antunes LM. 2012. Dietary carotenoid lutein protects against DNA damage and alterations of the redox status induced by cisplatin in human derived HepG2 cells. Toxicol in Vitro. 26:288-294
13. Shi R, Huang Q, Zhu X, Ong YB, Zhao B, Lu J, Ong CN, Shen HM. 2007. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-Terminal kinase-mediated p53 phosphorylation and stabilization. Mol Cancer Therapeutics. 6:1338-1347
14. Wang W, Sun Y, Li X, Li H, Chen Y, Tian Y, Yi J, Wang J. 2011. Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression. Oncol Rep. 26:1143-1148
15. Wei W, Mok SC, Oliva E, Kim SH, Mohapatra G, Birrer MJ. 2013. FGF18 as a prognostic and therapeutic biomarker in ovarian cancer. J Clin Invest. 123:4435-4448.